News
Guideline preview: ASH to recommend against VTE prophylaxis for lower-risk cancer patients
- Author:
- Andrew D. Bowser
ATLANTA – ASH attendees got a preview of forthcoming recommendations on prevention and treatment of VTE in patients with cancer.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/DeAngelo_Daniel_web.jpg)
Avapritinib yields high response rate in patients with systemic mastocytosis
- Author:
- Andrew D. Bowser
ATLANTA – Avapritinib was well tolerated in the phase 1 trial, and demonstrated encouraging preliminary activity.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/Hoppe_Carolyn_web.jpg)
Polymerization inhibitor improves hemoglobin levels in adolescents with SCD
- Author:
- Andrew D. Bowser
ATLANTA – Voxelotor demonstrated consistent, sustained improvements in hemoglobin levels in adolescents with sickle cell disease in a phase 2b...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Cowl_Clayton_T_web.jpg)
Hyperbaric oxygen may cut CO deaths
- Author:
- Andrew D. Bowser
Undergoing more hyperbaric oxygen sessions reduced the mortality rate in a study of patients with carbon monoxide poisoning.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/deep_vein_thrombosis2_web.jpg)
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
- Author:
- Andrew D. Bowser
The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Genes_DNA_1_web.jpg)
Gene therapy found promising in patients with hemophilia B
- Author:
- Andrew D. Bowser
The treatment prevented bleeding and virtually eliminated the need for exogenous factors.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2017/Silberstein_Stephen_web.jpg)
Fremanezumab may reduce chronic migraine frequency
- Author:
- Andrew D. Bowser
Participants saw reductions of between 4 and 5 migraine and headache days per month with the drug over 12 weeks.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2017/129360_photo_web.jpg)
Vasopressin stimulates red blood cell production
- Author:
- Andrew D. Bowser
The findings could have implications for the development of new treatments designed to stimulate RBC production after bleeding, chemotherapy, or...
News
Radiofrequency ablation improves stent patency in malignant biliary strictures
- Author:
- Andrew D. Bowser
The results are limited and preliminary.
News
Mutations influence prognostic value of tumor location in stage III colon cancer
- Author:
- Andrew D. Bowser
In patients with BRAF or RAS mutations, DFS was better in right-sided vs. left-sided tumors, while in patients with RAS and BRAF double wild type...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/diabetes_1_web.jpg)
Does incretin therapy increase pancreatic cancer risk?
- Author:
- Andrew D. Bowser
It is unlikely the drugs actually caused the increase in cancer risk.
News
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more
- Author:
- Andrew D. Bowser
ASH President Kenneth C. Anderson, MD, and ASH Secretary Robert A. Brodsky, MD, gave a preview of four practice-changing studies.
News
Squamous cell carcinoma linked to 25% increase in all-cause mortality
- Author:
- Andrew D. Bowser
Patients with SCC “may need additional education and age-appropriate screening to prevent deaths from major diseases,” the authors concluded.
News
FDA authorizes next-generation sequencing test for tumor profiling
- Author:
- Andrew D. Bowser
MSK-IMPACT is a custom targeted sequencing platform that uses exon capture and sequencing to identify point mutations, small insertions and...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2017/mantle_cell_lymphoma_2017_web.jpg)
Rituximab key to survival after transplant for mantle cell lymphoma
- Author:
- Andrew D. Bowser
The benefit of rituximab “stands out, and adds to the increasing body of evidence supporting this practice for all MCL patients after ASCT,...